Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3346 AL 3360

Older Adults with Alzheimer's Disease Who Have Used an Automatic Medication Dispenser for 3 or More Years

Kamimura T.

Clin Gerontol. 2019 Jan-Feb;42(1):127-133. doi: 10.1080/07317115.2017.1347594. Epub 2017 Oct 13.

Editorial: Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives

Kamal MA, Greig NH.

Curr Alzheimer Res. 2017;14(11):1138-1139. doi: 10.2174/156720501411171006122827.

Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data

Ozawa C, Roberts R, Yoshida K, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1204-e1210. doi: 10.4088/JCP.17m11461.

Amyloid PET scan: Staging beyond reading?

Chételat G, Murray ME.

Neurology. 2017 Nov 14;89(20):2029-2030. doi: 10.1212/WNL.0000000000004678. Epub 2017 Oct 18.

Ethique: Quelques questions face à la démence

Hurst S.

Praxis (Bern 1994). 2017;106(22):1211-1213. doi: 10.1024/1661-8157/a002844.

[Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]

Watanabe H.

Yakugaku Zasshi. 2017;137(11):1361-1365. doi: 10.1248/yakushi.17-00156.

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease

Chakravarthy M, Chen S, Dodd PR, Veedu RN.

Theranostics. 2017 Sep 5;7(16):3933-3947. doi: 10.7150/thno.21529. eCollection 2017.

Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease

Hunter S, Brayne C.

Mol Psychiatry. 2018 Jan;23(1):81-93. doi: 10.1038/mp.2017.218. Epub 2017 Nov 7.

Alzheimer's Disease-Current Status and Future Directions

Bhardwaj D, Mitra C, Narasimhulu CA, Riad A, Doomra M, Parthasarathy S.

J Med Food. 2017 Dec;20(12):1141-1151. doi: 10.1089/jmf.2017.0093. Epub 2017 Nov 13.

The Support, Health, Activities, Resources, and Education program for early stage dementia: Results from a randomized controlled trial

Whitlatch CJ, Heid AR, Femia EE, Orsulic-Jeras S, Szabo S, Zarit SH.

Dementia (London). 2019 Aug;18(6):2122-2139. doi: 10.1177/1471301217743033. Epub 2017 Nov 24.

Genetic screening in two Iranian families with early-onset Alzheimer's disease identified a novel PSEN1 mutation

Wang JC, Alinaghi S, Tafakhori A, Sikora E, Azcona LJ, Karkheiran S, Goate A, Paisán-Ruiz C, Darvish H.

Neurobiol Aging. 2018 Feb;62:244.e15-244.e17. doi: 10.1016/j.neurobiolaging.2017.10.011. Epub 2017 Oct 23.

Developing Disease-Modifying Treatments in Alzheimer's Disease - A Perspective from Roche and Genentech

Doody R.

J Prev Alzheimers Dis. 2017;4(4):264-272. doi: 10.14283/jpad.2017.40.

Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential

Abushakra S, Porsteinsson A, Scheltens P, Sadowsky C, Vellas B, Cummings J, Gauthier S, Hey JA, Power A, Wang P, Shen L, Tolar M.

J Prev Alzheimers Dis. 2017;4(3):149-156. doi: 10.14283/jpad.2017.26.

Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study

Kahle-Wrobleski K, Andrews JS, Belger M, Ye W, Gauthier S, Rentz DM, Galasko D.

J Prev Alzheimers Dis. 2017;4(2):72-80. doi: 10.14283/jpad.2017.2.

EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials

Aisen P, Touchon J, Amariglio R, Andrieu S, Bateman R, Breitner J, Donohue M, Dunn B, Doody R, Fox N, Gauthier S, Grundman M, Hendrix S, Ho C, Isaac M, Raman R, Rosenberg P, Schindler R, Schneider L, Sperling R, Tariot P, Welsh-Bohmer K, Weiner M, Vellas B.

J Prev Alzheimers Dis. 2017;4(2):116-124. doi: 10.14283/jpad.2017.13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias